MER Primary Care Conferences Internal Medicine for Primary Care Cardio Endo Nephro Sep 18-20, 2026

MER Cardiology Endocrinology Nephrology 2026 is a digital study resource associated with the MER Internal Medicine for Primary Care conference. Review cardiology, endocrinology and nephrology topics from the September 18–20, 2026 primary care conference. This purchase is not conference registration and does not include a MER account, CME credit or a certificate.

Course Overview

The MER Primary Care Conferences Internal Medicine for Primary Care: Cardiology/Endocrinology/Nephrology 2026 program, organized by Medical Education Resources (MER), provides an evidence-based review of common and complex medical conditions encountered in primary care and internal medicine practice.

Held September 18–20, 2026, at The Ritz-Carlton, Laguna Niguel, California, this educational conference emphasizes practical diagnostic approaches, clinical decision-making, disease prevention, and contemporary treatment strategies.

The program addresses major clinical topics including cardiovascular disease prevention, coronary artery disease, heart failure, atrial fibrillation, osteoporosis, calcium metabolism disorders, chronic kidney disease, diabetic nephropathy, glomerulonephritis, and electrolyte abnormalities.

Through case-based discussions and guideline-focused presentations, healthcare professionals can strengthen their understanding of clinical management across three closely connected medical specialties.

Course Details

• Course Title: MER Primary Care Conferences Internal Medicine for Primary Care Cardio Endo Nephro Sep 18-20, 2026
• Organizer: Medical Education Resources (MER)
• Conference Dates: September 18–20, 2026
• Location: The Ritz-Carlton, Laguna Niguel, Laguna Beach, California, USA
• Specialties: Internal Medicine, Cardiology, Endocrinology, Nephrology
• Educational Format: Continuing Medical Education Conference
• Original Conference Credit Designation: Up to 12 AMA PRA Category 1 Credits™ for eligible participation in the live activity
• Language: English

The original conference accreditation does not imply that purchasing educational materials separately provides CME credits.

Target Audience

This program is designed for healthcare professionals seeking clinical updates in internal medicine and primary care, particularly:

• Primary Care Physicians
• Internal Medicine Physicians
• Family Medicine Physicians
• Cardiologists
• Endocrinologists
• Nephrologists
• Nurse Practitioners
• Physician Assistants
• Other healthcare professionals involved in adult patient care

Program Overview

The conference integrates three major medical specialties to provide a clinically relevant educational experience.

Cardiology

Explore contemporary approaches to cardiovascular disease prevention, lipid management, coronary artery disease evaluation, heart failure treatment, and arrhythmia management.

Endocrinology

Review calcium metabolism, metabolic bone diseases, osteoporosis diagnosis and treatment, DEXA interpretation, FRAX assessment, and endocrine case management.

Nephrology

Examine chronic kidney disease management, SGLT2 inhibitor therapy, diabetic kidney disease, glomerulonephritis, and common electrolyte and acid-base disturbances.

Original conference agenda

The topics below match the MER agenda dated June 10, 2026. They describe the original program, not a verified inventory of delivered files; file count, formats and completeness have not been independently checked.

Day 1 — Friday, September 18, 2026

Endocrinology

1. Disorders of Calcium Metabolism

• Calcium homeostasis and regulation
• Causes of hypercalcemia
• Diagnostic evaluation of calcium abnormalities
• Treatment of calcium metabolism disorders

2. Metabolic Bone Disease

• Disorders of mineral and vitamin D metabolism
• Calcium and phosphorus regulation
• Osteomalacia and Paget’s disease
• Parathyroid disorders and bone health

3. Osteoporosis

• Epidemiology and pathophysiology of osteoporosis
• DEXA scan interpretation
• FRAX fracture risk assessment
• Current pharmacological treatment options

Nephrology

4. Should All Patients with CKD be on SGLT2 Inhibitors?

• Role of SGLT2 inhibitors in chronic kidney disease
• Kidney and cardiovascular benefits
• Guideline-directed medical therapy
• Treatment considerations in patients with and without diabetes

5. Glomerulonephritis 101

• Recognition and diagnosis of glomerulonephritis
• Differentiating glomerular diseases
• IgA nephropathy
• Emerging and approved therapeutic approaches

Day 2 — Saturday, September 19, 2026

Nephrology

6. Managing Diabetic Kidney Disease: New Insights and Therapies

• Early identification of diabetic kidney disease
• Diagnosis and progression of chronic kidney disease
• New treatment strategies
• Nonsteroidal mineralocorticoid receptor antagonists
• GLP-1 receptor agonists and kidney outcomes

7. Primary Care Primer on Electrolytes

• Sodium disorders
• Potassium imbalances
• Bicarbonate and acid-base abnormalities
• Case-based diagnosis and treatment

Endocrinology

8. Endocrinology Cases: Calcium Disorders and Osteoporosis

• Clinical case discussions
• Diagnostic and therapeutic decision-making
• Calcium abnormalities
• Individualized osteoporosis treatment planning

Cardiology

9. Primary Prevention of Cardiometabolic CVD

• Cardiovascular risk assessment
• Lipid and cholesterol guidelines
• Metabolic syndrome and obesity
• Lifestyle modification and exercise
• Preventive pharmacotherapy
• Cardiac rehabilitation

10. Work-up of Patients with Suspected CAD

• Coronary artery disease risk factors
• Chest pain evaluation
• ACC/AHA chest pain guidance
• ECG, echocardiography, and cardiac imaging
• CT-based evaluation
• Special populations with suspected CAD

Day 3 — Sunday, September 20, 2026

Cardiology

11. Heart Failure

• Heart failure classification and staging
• HFrEF and HFpEF
• ACC/AHA guideline-based management
• ACE inhibitors, ARBs, ARNI, and beta-blockers
• Mineralocorticoid receptor antagonists and SGLT2 inhibitors
• NT-proBNP and other biomarkers
• Device therapy and referral considerations
• Acute decompensated heart failure

12. Arrhythmias

• Evaluation of palpitations
• Common cardiac arrhythmias
• Atrial fibrillation diagnosis and treatment
• Stroke risk assessment
• Anticoagulation strategies
• Rate versus rhythm control
• Ventricular arrhythmias and referral indications

MER original conference agenda documents the source program. Accreditation and live participation benefits apply to the original activity, not this file purchase.